Schlessinger J - Search Results

1

Randomized sham-controlled trial to evaluate the safety and effectiveness of a high-intensity focused ultrasound device for noninvasive body sculpting.

Jewell ML, Baxter RA, Cox SE, Donofrio LM, Dover JS, Glogau RG, Kane MA, Weiss RA, Martin P, Schlessinger J. Jewell ML, et al. Among authors: schlessinger j. Plast Reconstr Surg. 2011 Jul;128(1):253-262. doi: 10.1097/PRS.0b013e3182174278. Plast Reconstr Surg. 2011. PMID: 21701341 Clinical Trial.

2

The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment.

Rubin MG, Dover J, Glogau RG, Goldberg DJ, Goldman MP, Schlessinger J. Rubin MG, et al. Among authors: schlessinger j. J Drugs Dermatol. 2009 May;8(5):439-44. J Drugs Dermatol. 2009. PMID: 19537366 Clinical Trial.

3

An analysis of the long-term safety data of repeat administrations of botulinum neurotoxin type A-ABO for the treatment of glabellar lines.

Cohen JL, Schlessinger J, Cox SE, Lin X; Reloxin Investigational Group. Cohen JL, et al. Among authors: schlessinger j. Aesthet Surg J. 2009 Nov;29(6 Suppl):S43-9. doi: 10.1016/j.asj.2009.09.003. Aesthet Surg J. 2009. PMID: 19945004

4

Time to onset of response of abobotulinumtoxina in the treatment of glabellar lines: a subset analysis of phase 3 clinical trials of a new botulinum toxin type A.

Schlessinger J, Monheit G, Kane MA, Mendelsohn N. Schlessinger J, et al. Dermatol Surg. 2011 Oct;37(10):1434-42. doi: 10.1111/j.1524-4725.2011.02075.x. Epub 2011 Jul 11. Dermatol Surg. 2011. PMID: 21745254 Clinical Trial.

5

Current aesthetic use of abobotulinumtoxinA in clinical practice: an evidence-based consensus review.

Maas C, Kane MA, Bucay VW, Allen S, Applebaum DJ, Baumann L, Cox SE, Few JW, Joseph JH, Lorenc ZP, Moradi A, Nestor MS, Schlessinger J, Wortzman M, Lawrence I, Lin X, Nelson D. Maas C, et al. Among authors: schlessinger j. Aesthet Surg J. 2012 Sep;32(1 Suppl):8S-29S. doi: 10.1177/1090820X12455192. Aesthet Surg J. 2012. PMID: 22941910 Review.

6

Safety and tolerability of high-intensity focused ultrasonography for noninvasive body sculpting: 24-week data from a randomized, sham-controlled study.

Jewell ML, Weiss RA, Baxter RA, Cox SE, Dover JS, Donofrio LM, Glogau RG, Kane MC, Martin P, Lawrence ID, Schlessinger J. Jewell ML, et al. Among authors: schlessinger j. Aesthet Surg J. 2012 Sep;32(7):868-76. doi: 10.1177/1090820X12455190. Aesthet Surg J. 2012. PMID: 22942114 Clinical Trial.

7

A randomized, placebo-controlled, double-blind phase III trial investigating the efficacy and safety of incobotulinumtoxinA in the treatment of glabellar frown lines using a stringent composite endpoint.

Hanke CW, Narins RS, Brandt F, Cohen JL, Donofrio LM, Downie J, Heinz M, Harrington L, McDaniel DH, Nestor M, Schlessinger J, Schlöbe A, Taub A, Weiss RA. Hanke CW, et al. Among authors: schlessinger j. Dermatol Surg. 2013 Jun;39(6):891-9. doi: 10.1111/dsu.12160. Epub 2013 Mar 18. Dermatol Surg. 2013. PMID: 23506308 Clinical Trial.

8

Perceptions and practices in submental fat treatment: a survey of physicians and patients.

Schlessinger J, Weiss SR, Jewell M, Narurkar V, Weinkle S, Gold MH, Bazerkanian E. Schlessinger J, et al. Skinmed. 2013 Jan-Feb;11(1):27-31. Skinmed. 2013. PMID: 23540074

9

Long-term safety of abobotulinumtoxinA for the treatment of glabellar lines: results from a 36-month, multicenter, open-label extension study.

Schlessinger J, Dover JS, Joseph J, Monheit G, Nelson DB, Albright CD, Axford-Gatley RA, Cohen JL; Dysport Study Group. Schlessinger J, et al. Dermatol Surg. 2014 Feb;40(2):176-83. doi: 10.1111/dsu.12404. Epub 2013 Dec 26. Dermatol Surg. 2014. PMID: 24372978 Clinical Trial.

10

Efficacy and Safety of ATX-101 by Treatment Session: Pooled Analysis of Data From the Phase 3 REFINE Trials.

Dayan SH, Schlessinger J, Beer K, Donofrio LM, Jones DH, Humphrey S, Carruthers J, Lizzul PF, Gross TM, Beddingfield FC 3rd, Somogyi C. Dayan SH, et al. Among authors: schlessinger j. Aesthet Surg J. 2018 Aug 16;38(9):998-1010. doi: 10.1093/asj/sjy008. Aesthet Surg J. 2018. PMID: 29401213 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

600 results

Search Page

Filters